3510429-m01annc

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.


This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for the securities.


Bloomage BioTechnology Corporation Limited

華 熙 生 物 科 技 有 限 公 司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 00963)


COMPLETION OF THE ISSUE OF CONVERTIBLE BONDS AND SUBSCRIPTION SHARES UNDER GENERAL MANDATE



Sole Placing Agent


Reference is made to the announcement of Bloomage BioTechnology Corporation Limited (the 'Company') dated 5 November 2015 (the 'Announcement') in respect of, among other things, the issue of the Convertible Bonds and the Subscription Shares under General Mandate. Unless otherwise defined herein, capitalised terms used herein shall bear the same meanings as those defined in the Announcement.


SUBSCRIPTION COMPLETION


The Board is pleased to announce that, following fulfilment of all of the Conditions Precedent, the Subscription Completion took place on 20 November 2015 in accordance with the terms of the Subscription Agreement.


On the date of the Subscription Completion, (i) the Convertible Bonds in the aggregate principal amount of HK$465,000,000 were issued by the Company to the Investor at the Bond Subscription Price equal to 100 per cent of the principal amount of the Convertible Bonds; and (ii) a total of 16,145,834 Subscription Shares, representing approximately 4.61% of the issued share capital of the Company as at

the date of this announcement, were allotted and issued by the Company to the Investor at the aggregate subscription consideration of HK$193,750,008, being the Subscription Price of HK$12.00 per Subscription Share multiplied by the number of Subscription Shares.



Hong Kong, 20 November 2015

By order of the Board

Bloomage BioTechnology Corporation Limited ZHAO YAN

Chairman


As at the date of this announcement, the executive Directors are Ms. Zhao Yan, Mr. Jin Xuekun, Ms. Liu Aihua and Ms. Wang Aihua; the non-executive Director is Mr. Guo Jiajun; and the independent non-executive Directors are Ms. Zhan Lili, Mr. Hai Wen and Mr. Li Junhong.

distributed by